RADNOR, Pa., March 8, 2022 /PRNewswire/ -- Avantor, Inc.
(NYSE: AVTR), a leading global provider of mission-critical
products and services to customers in the life sciences, advanced
technologies and applied materials industries, will participate in
the KeyBanc Life Sciences and Medtech Investor Forum being held
virtually on Tuesday, March 22,
2022. Dr. Ger Brophy, Executive
Vice President, Biopharma Production at Avantor, will discuss the
Company's biopharma production business and its priorities in the
fireside chat segment beginning at approximately 2:15 p.m. Eastern Daylight Time.
A live webcast can be accessed on the investors section of
Avantor's website and a replay will be available through
April 22, 2022.
About Avantor
Avantor®, a Fortune 500
company, is a leading global provider of mission-critical products
and services to customers in the biopharma, healthcare, education
& government, and advanced technologies & applied materials
industries. Our portfolio is used in virtually every stage of the
most important research, development and production activities in
the industries we serve. Our global footprint enables us to serve
more than 225,000 customer locations and gives us extensive access
to research laboratories and scientists in more than 180 countries.
We set science in motion to create a better world. For more
information, please visit www.avantorsciences.com.
Media Contact
Allison
Hosak
Senior Vice President, Global Communications and Brand
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com
Investor Relations Contact
Tommy Thomas
Vice President, Investor Relations
Avantor
781-375-8051
Tommy.Thomas@avantorsciences.com
View original
content:https://www.prnewswire.com/news-releases/avantor-to-participate-in-keybanc-life-sciences-and-medtech-investor-forum-301497003.html
SOURCE Avantor and Financial News